Hinge Health (NYSE:HNGE) CFO Sells $43,220.54 in Stock

Hinge Health Inc. (NYSE:HNGE) CFO James Budge sold 781 shares of the company’s stock in a transaction that occurred on Wednesday, May 20th. The shares were sold at an average price of $55.34, for a total transaction of $43,220.54. Following the completion of the transaction, the chief financial officer owned 451,293 shares of the company’s stock, valued at $24,974,554.62. This trade represents a 0.17% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

James Budge also recently made the following trade(s):

• On Monday, May 11th, James Budge sold 5,906 shares of Hinge Health stock. The shares were sold at an average price of $54.82, for a total transaction of $323,766.92.
• On Monday, March 23rd, James Budge sold 11,006 shares of Hinge Health stock. The stock was sold at an average price of $42.26, for a total transaction of $465,113.56.

Hinge Health Trading Down 0.0%

Shares of HNGE opened at $55.10 on Friday. Hinge Health Inc. has a 12 month low of $30.08 and a 12 month high of $62.18. The firm has a fifty day simple moving average of $45.04 and a 200 day simple moving average of $44.43. The stock has a market capitalization of $4.26 billion and a price-to-earnings ratio of -4.46.

Hinge Health (NYSE:HNGE) last announced its earnings results on Tuesday, May 5th. The company reported $0.45 EPS for the quarter, topping the consensus estimate of $0.12 by $0.33. Hinge Health had a negative net margin of 78.95% and a negative return on equity of 310.62%. The business had revenue of $182.31 million during the quarter. During the same quarter in the previous year, the company posted $1.30 EPS. The business’s revenue for the quarter was up 47.2% compared to the same quarter last year. As a group, research analysts predict that Hinge Health Inc. will post 1.21 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the stock. Piper Sandler restated an “overweight” rating and set a $95.00 target price on shares of Hinge Health in a report on Wednesday, May 6th. Needham & Company LLC increased their target price on shares of Hinge Health from $59.00 to $63.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. Citizens Jmp increased their target price on shares of Hinge Health from $65.00 to $80.00 and gave the stock a “market outperform” rating in a report on Wednesday, May 6th. Evercore restated an “outperform” rating and set a $45.00 target price on shares of Hinge Health in a report on Wednesday, April 8th. Finally, Barclays increased their target price on shares of Hinge Health from $52.00 to $62.00 and gave the stock an “overweight” rating in a report on Wednesday, May 6th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $67.40.

Hedge Funds Weigh In On Hinge Health

Large investors have recently modified their holdings of the stock. Wells Fargo & Company MN raised its position in shares of Hinge Health by 160.0% in the fourth quarter. Wells Fargo & Company MN now owns 546 shares of the company’s stock valued at $25,000 after purchasing an additional 336 shares during the period. Caitong International Asset Management Co. Ltd bought a new position in shares of Hinge Health in the fourth quarter valued at about $26,000. Mirae Asset Global Investments Co. Ltd. bought a new position in shares of Hinge Health in the third quarter valued at about $37,000. CENTRAL TRUST Co bought a new position in shares of Hinge Health in the first quarter valued at about $37,000. Finally, First Horizon Corp raised its position in shares of Hinge Health by 163.9% in the fourth quarter. First Horizon Corp now owns 855 shares of the company’s stock valued at $40,000 after purchasing an additional 531 shares during the period.

Hinge Health Company Profile

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.